SpringWorks Therapeutics to Be Acquired by Germany's Merck in $3.9 Billion Deal
In This Article:
SpringWorks Therapeutics (SWTX) stock rose early Monday after the biopharmaceutical company agreed t
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.